"DUVAT 2025" Explores the latest innovations in the pharmaceutical industry
DUBAI, 5 JANUARY / WAM / The Dubai International Pharmaceutical and Technology Conference and Exhibition (DUPHAT 2025), scheduled to begin at the Dubai World Trade Center the day after tomorrow, Tuesday, and continue for three days, brings together more than 1,376 leading global companies in the field of pharmaceuticals and health technology, to explore the latest innovations and technologies in Pharmaceutical industry.
DUPHAT is the largest event in the Middle East and Africa region in the pharmaceutical industry, as it is expected to attract more than 31,680 visitors from 101 countries, and includes 130 scientific sessions and 9 workshops, in addition to the participation of 400 scientific posters from university students. This edition of The event, for the first time, is the “Vita Show Dubai” event to showcase the latest innovations in nutritional supplements.
The event provides participants with the opportunity to explore the latest innovations and technologies in the industry, in addition to exchanging ideas and visions about the future of the pharmacy and health sector, as it aims to enhance international cooperation in the field of medicines, support innovation and encourage research and development, in line with the UAE’s vision of enhancing its health status at the global level. And achieving sustainable development goals.
Over the course of 30 years, DUPHAT has become a leading global platform in the field of pharmacy, providing exceptional opportunities for pharmaceutical suppliers and healthcare companies to communicate, review the latest products, and learn about the latest developments in pharmaceutical technologies. It also represents an important opportunity to exchange knowledge and experiences between companies and specialists in The medical sector, and reviews everything new in the field of medicines and patient care.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and
